| __timestamp | Bausch Health Companies Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 44820000 |
| Thursday, January 1, 2015 | 2682700000 | 82080000 |
| Friday, January 1, 2016 | 2810000000 | 97130000 |
| Sunday, January 1, 2017 | 2582000000 | 121271000 |
| Monday, January 1, 2018 | 2473000000 | 153548000 |
| Tuesday, January 1, 2019 | 2554000000 | 202541000 |
| Wednesday, January 1, 2020 | 2367000000 | 245164000 |
| Friday, January 1, 2021 | 2624000000 | 285773000 |
| Saturday, January 1, 2022 | 2625000000 | 325998000 |
| Sunday, January 1, 2023 | 2917000000 | 332540000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of the pharmaceutical industry, operational efficiency is paramount. Over the past decade, PTC Therapeutics, Inc. and Bausch Health Companies Inc. have showcased contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Bausch Health's SG&A expenses have consistently dwarfed those of PTC Therapeutics, averaging nearly 14 times higher. Notably, Bausch Health's expenses peaked in 2023, marking a 44% increase from 2014. Meanwhile, PTC Therapeutics exhibited a more dynamic growth, with a staggering 642% rise in SG&A expenses over the same period. This divergence highlights the distinct strategic approaches of these companies, with Bausch Health maintaining a steady operational scale, while PTC Therapeutics aggressively expands its footprint. As the industry continues to evolve, these trends offer a glimpse into the strategic priorities shaping the future of these pharmaceutical giants.
Comparing SG&A Expenses: Johnson & Johnson vs Bausch Health Companies Inc. Trends and Insights
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Xencor, Inc.
Bausch Health Companies Inc. or Evotec SE: Who Manages SG&A Costs Better?